WAT Waters Corp
XNYS
449.88
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $282.77 – $465.36
- YTD
- +17.78%
- IV Rank (30D)
- 62.49
- Straddle Price
- $42.00
- P/C Vol Ratio
- 3.64
- Market Cap
- $44.8B
- Open
- $458.16
- Day Range
- $446.70 – $458.16
- Volume
- 500,526
- Prev Close
- $455.59
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 0.94 |
| Cost of Equity (CAPM) | 9.81% (VRP-adj) |
| WACC | 9.28% |
| Volatility Risk Premium | +35.9pp (IV − HV30) |
| Effective Tax Rate | 19.1% |
| Rev. Growth (YoY, DCF input) | +30.0% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.4B |
| Return on Equity (TTM) | 1.1% |
| Book / Price | 44.5% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 50.9% |
| FCF Margin (TTM) | 8.6% |
| Debt / Equity | 0.32 |
| Quality Score | 3/6 — normal (10y DCF) |
| SMA 50 | $423.33 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $437.72 |
| Bollinger Width / SMA20 | 1.7% (drives anchor stability) |
| Net Debt | $4.3B |
| Market Cap | $34B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $325.29 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $69.08 | 5% | median 15.7× · 3 peers |
| Peer EV/EBITDA | $62.52 | 6% | median 14.8× · 3 peers |
| Peer P/B | $425.74 | 7% | median 2.1× · 3 peers |
| Peer P/S | $323.77 | 7% | median 4.8× · 3 peers |
| Market Anchor (SMA50) | $423.33 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $460.04 | 19% | 29 strikes · skew +0.37 |
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNYS
- Market Cap
- $44.8B
- Employees
- 7,900
- List Date
- 1995-11-17
- CIK
- 0001000697
- Next Earnings
- 2026-11-03 (Pre-Market)
- EPS Forecast
- $3.99 (7 est.)
- Headquarters
- Milford, MA
- Homepage
- https://www.waters.com
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 5.80% | -12.20% | -4.92% | -3.32% | 12.82% | -2.94% | -0.79% |
| Feb | 1.89% | -2.16% | -8.03% | 4.00% | -8.23% | -15.80% | -4.72% |
| Mar | 2.57% | -1.02% | 0.12% | -0.52% | -0.87% | -3.07% | -0.47% |
| Apr | 5.32% | -1.80% | -2.31% | -10.30% | -2.32% | 3.11% | -1.38% |
| May | 6.82% | 8.46% | -15.76% | -2.22% | 2.17% | 24.89% | 4.06% |
| Jun | 8.51% | 2.85% | 4.10% | -6.38% | 1.56% | -0.83% | 1.64% |
| Jul | 11.00% | 8.06% | 4.32% | 18.95% | -19.12% | -0.37% | 3.81% |
| Aug | 6.47% | -18.31% | 2.33% | -1.75% | 3.96% | 10.64% | 0.56% |
| Sep | -14.14% | -10.26% | -2.42% | 5.93% | 1.12% | 8.27% | -1.92% |
| Oct | 3.33% | 7.87% | -11.83% | -9.83% | 9.31% | 5.94%* | 0.80% |
| Nov | -10.02% | 12.74% | 16.51% | -0.64% | 16.73% | -- | 7.06% |
| Dec | 13.42% | -1.25% | 13.98% | -4.16% | -4.51% | -- | 3.50% |
| Total | 44.44% | -11.39% | -8.52% | -12.69% | 7.77% | 27.91% | 7.92% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: WAT
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers and Primary Risks:
- Technical trend indicators suggest a weak uptrend, with the SMA 20 above the price.
- Momentum oscillators are neutral, indicating no strong buying or selling pressure.
- Bollinger Bands indicate a squeeze in volatility, which could lead to a breakout or mean reversion.
- Recent news headlines have been positive, but options market sentiment is bearish.
Investment Thesis:
WAT's recent price action is characterized by a weak uptrend and neutral momentum. While the stock has received positive news coverage, options market sentiment suggests caution. We recommend monitoring key levels and catalysts to determine potential entry or exit points.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): NEUTRAL; Medium-term (1-3 months): WEAK UPTREND; Long-term (3-12 months): NO CLEAR TREND
Support/Resistance Levels:
- Lower band: $368.94
- Middle band: $398.92
- Upper band: $428.90
- SMA 20: $398.92
- EMA 12: $405.88
- MACD signal line: -0.33
Momentum Signals:
- RSI (14): 59.42 (neutral)
- Stochastic %K: 76.53
- Stochastic %D: 75.00
- Williams %R: -26.13
- MACD: Bullish signal, but weak
News & Sentiment Analysis
Recent Headlines Summary: The last 10 news headlines are mostly positive, focusing on the mass spectrometry and laboratory equipment services markets.
Sentiment Assessment: Aggregate sentiment is POSITIVE (7/10)
Catalyst Identification: No specific catalysts identified in recent news; however, upcoming earnings reports could be a key event.
Market Narrative: News sentiment aligns with the neutral technical picture, indicating no strong buying or selling pressure.
Risk & Volatility Assessment
Beta Interpretation: Beta 0.89 indicates moderate volatility relative to the market.
Volatility Regime: Current volatility is lower than historical levels (HV30: 31.8%).
Options Market Signals: IV rank is medium, with options market pricing a $31.30 move by expiration. Put-call volume ratio is bearish, indicating caution.
Market Context & Positioning
Sector Performance: WAT's sector, life sciences, has been performing well recently, but the stock itself is not strongly correlated (R-squared: 0.21).
Institutional Activity: Volume patterns suggest institutional interest, with a slightly higher volume on up days.
Correlation Analysis: R-squared interpretation indicates no strong correlation between WAT and market movements.
Key Levels & Action Items
Critical Price Levels:
- Lower band: $368.94
- Middle band: $398.92
- Upper band: $428.90
Breakout/Breakdown Levels:
- SMA 20: $398.92 (uptrend support)
- EMA 12: $405.88 (short-term resistance)
Time-Sensitive Catalysts: Upcoming earnings reports could be a key event.
Risk Management: Monitor key levels and catalysts to determine potential entry or exit points. Consider stop-loss levels based on volatility and market conditions.
This analysis provides an objective view of WAT's technical, news, and options market signals, highlighting the stock's neutral trend and moderate volatility.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-02 | Pre-Market | 8.55% | 8.37% | 0.98x | Within |
| 2021-05-05 | Pre-Market | 6.02% | 2.91% | 0.48x | Within |
| 2021-08-03 | Pre-Market | 6.71% | 0.75% | 0.11x | Within |
| 2021-11-02 | Pre-Market | 6.62% | 4.31% | 0.65x | Within |
| 2022-02-01 | Pre-Market | 8.72% | 1.12% | 0.13x | Within |
| 2022-05-03 | Pre-Market | 8.94% | 8.12% | 0.91x | Within |
| 2022-08-02 | Pre-Market | 5.74% | 6.84% | 1.19x | Exceeded |
| 2022-11-01 | Pre-Market | 3.84% | 2.76% | 0.72x | Within |
| 2023-02-15 | Pre-Market | 4.83% | 0.71% | 0.15x | Within |
| 2023-05-09 | Pre-Market | 5.85% | 6.66% | 1.14x | Exceeded |
| 2023-08-02 | Pre-Market | 7.42% | 6.33% | 0.85x | Within |
| 2023-11-07 | Pre-Market | 8.69% | 3.38% | 0.39x | Within |
| 2024-02-06 | Pre-Market | 6.71% | 1.70% | 0.25x | Within |
| 2024-05-07 | Pre-Market | 6.71% | 1.94% | 0.29x | Within |
| 2024-07-31 | Pre-Market | 8.09% | 2.63% | 0.33x | Within |
| 2024-11-01 | Pre-Market | 7.86% | 19.84% | 2.52x | Exceeded |
| 2025-02-12 | Pre-Market | 7.09% | 5.77% | 0.81x | Within |
| 2025-05-06 | Pre-Market | 8.20% | 2.69% | 0.33x | Within |
| 2025-08-04 | Pre-Market | 7.49% | 1.63% | 0.22x | Within |
| 2025-11-04 | Pre-Market | 8.51% | 6.29% | 0.74x | Within |
| 2026-02-09 | Pre-Market | 6.58% | 13.94% | 2.12x | Exceeded |
| 2026-05-05 | Pre-Market | 9.71% | 13.54% | 1.39x | Exceeded |
| 2026-08-04 | Pre-Market | 9.99% | 5.69% | 0.57x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
WAT Options Activity & IV Rank
WAT IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 36th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Moderate volatility - stock generally follows market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Fundsmith Asset manager Terry Smith | $852.7M | #3 of 41 | -29.2% | 13F | |
| Viking Global Hedge fund Andreas Halvorsen | $623.4M | #22 of 90 | +32.3% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $335.5M | #52 of 3716 | +383.2% | 13F | |
| Point72 Hedge fund Steve Cohen | $166.6M | #89 of 1945 | +25.4% | 13F | |
| Citadel Hedge fund Ken Griffin | $50.9M | #679 of 6285 | -34.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $1.8M | #1438 of 4729 | -4.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
WAT Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | TUDOR INVESTMENT CORP ET AL | $62.41M | 58.05% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $15.71M | 14.62% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $14.28M | 13.29% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $6.99M | 6.50% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $3.15M | 2.93% | 2026-06-30 |
| 6 | Cubist Systematic Strategies, LLC | $1.74M | 1.62% | 2025-09-30 |
| 7 | Wolverine Trading, LLC Custodian | $1.07M | 1.00% | 2025-09-30 |
| 8 | Goldman Sachs Group Inc Custodian | $989.73K | 0.92% | 2026-06-30 |
| 9 | Simplex Trading, LLC Custodian | $525.06K | 0.49% | 2026-06-30 |
| 10 | Wells Fargo & Company Custodian | $300.03K | 0.28% | 2026-06-30 |
| 11 | Walleye Capital LLC | $262.53K | 0.24% | 2026-06-30 |
| 12 | GROUP ONE TRADING LLC Custodian | $37.50K | 0.03% | 2026-06-30 |
| 13 | UBS Group AG Custodian | $37.50K | 0.03% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wells Fargo & Company Custodian | $62.37M | 66.71% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $10.58M | 11.31% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $6.34M | 6.78% | 2026-06-30 |
| 4 | Jane Street Group, LLC Custodian | $4.79M | 5.12% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $4.58M | 4.89% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $2.36M | 2.53% | 2026-06-30 |
| 7 | Cubist Systematic Strategies, LLC | $1.41M | 1.51% | 2025-09-30 |
| 8 | Wolverine Trading, LLC Custodian | $781.46K | 0.84% | 2025-09-30 |
| 9 | Two Sigma Investments, LP Custodian | $225.02K | 0.24% | 2026-06-30 |
| 10 | GROUP ONE TRADING LLC Custodian | $37.50K | 0.04% | 2026-06-30 |
| 11 | Walleye Capital LLC | $37.50K | 0.04% | 2026-06-30 |
WAT Insider Trading (Form 4)
Latest: 2026-10-02| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Heather Knight | Director | Award (A) | +57 | — | EDGAR | |
| 2026-10-02 | Wei Jiang | Director | Award (A) | +57 | — | EDGAR | |
| 2026-08-07 | Christopher A Kuebler | Director | Mixed | — | $267.19 | -$948.2K | EDGAR |
| 2026-08-07 | Christopher A Kuebler | Director | Mixed | — | $267.19 | -$948.2K | EDGAR |
| 2026-07-02 | Wei Jiang | Director | Award (A) | +67 | — | EDGAR | |
| 2026-07-02 | Heather Knight | Director | Award (A) | +63 | — | EDGAR | |
| 2026-06-25 | Robert L Carpio III | SVP Waters Analytical Sciences | Tax (F) | −189 | $369.18 | -$69.8K | EDGAR |
| 2026-05-14 | Amol Chaubal | SVP & Chief Financial Officer | Tax (F) | −239 | $352.21 | -$84.2K | EDGAR |
| 2026-04-07 | Jianqing Bennett | SVP Waters Adv. Diagnostics | Tax (F) | −302 | $304.09 | -$91.8K | EDGAR |
| 2026-04-02 | Heather Knight | Director | Award (A) | +68 | — | EDGAR | |
| 2026-04-02 | Wei Jiang | Director | Award (A) | +64 | — | EDGAR | |
| 2026-03-18 | Wei Jiang | Director | Buy (P) | +500 | $289.46 | $144.7K | EDGAR |
| 2026-03-10 | Richard H Fearon | Director | Buy (P) | +1,000 | $306.34 | $306.3K | EDGAR |
| 2026-03-03 | Jianqing Bennett | SVP Waters Adv. Diagnostics | Tax (F) | −410 | $307.23 | -$126.0K | EDGAR |
| 2026-03-03 | Amol Chaubal | SVP & Chief Financial Officer | Tax (F) | −709 | $307.23 | -$217.8K | EDGAR |
WAT Insider Holdings
14 insiders · @ $450.35| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Udit Batra | President and CEO | 33,140 | $14.92M | $0 | 15 | 2026-03-03 |
| 2 | Christopher A Kuebler | Director | 21,434 | $9.65M | -$12.88M | 52 | 2026-08-07 |
| 3 | Amol Chaubal | SVP & Chief Financial Officer | 7,834 | $3.53M | $0 | 14 | 2026-05-14 |
| 4 | Jianqing Bennett | SVP Waters Adv. Diagnostics | 6,532 | $2.94M | $0 | 14 | 2026-04-07 |
| 5 | Flemming Ornskov | Director | 5,271 | $2.37M | $0 | 19 | 2026-02-27 |
| 6 | Mark Vergnano | Director | 4,540 | $2.04M | $997.9K | 7 | 2026-02-27 |
| 7 | Wei Jiang | Director | 3,630 | $1.63M | $144.7K | 29 | 2026-10-02 |
| 8 | Robert L Carpio III | SVP Waters Analytical Sciences | 3,426 | $1.54M | $0 | 6 | 2026-06-25 |
| 9 | Richard H Fearon | Director | 3,302 | $1.49M | $639.2K | 7 | 2026-03-10 |
| 10 | Pearl S Huang | Director | 3,276 | $1.48M | $0 | 23 | 2026-02-27 |
WAT Board & Officers
As of SEC filings through Oct 2, 2026Directors 11
- Christopher A Kuebler · since May 11, 2006
- Flemming Ornskov · since Jun 22, 2017
- Linda Baddour · since Sep 1, 2018
- Udit Batra · since Sep 1, 2020
- Pearl S Huang · since Jan 1, 2021
- Wei Jiang · since Jul 14, 2021
- Daniel J. Brennan · since Nov 23, 2022
- Mark Vergnano · since Nov 23, 2022
- Richard H Fearon · since Mar 27, 2023
- Heather Knight · since Aug 14, 2024
- Claire Fraser · since Feb 9, 2026
Officers 5
- Udit Batra · President and CEO · since Sep 1, 2020
- Amol Chaubal · SVP & Chief Financial Officer · listed since Feb 2022
- Jianqing Bennett · SVP Waters Adv. Diagnostics · listed since Feb 2026
- Robert L Carpio III · SVP Waters Analytical Sciences · listed since Feb 2026
- Tong (NMN) Wu · SVP Waters Analytical Sciences · since Aug 21, 2026
Changes in the last 10 years (41)
| Aug 21, 2026 | Tong (NMN) Wu became SVP Waters Analytical Sciences |
| Feb 27, 2026 | Robert L Carpio III listed as SVP Waters Analytical Sciences (previously SVP, Waters Division) in SEC filings |
| Feb 27, 2026 | Jianqing Bennett listed as SVP Waters Adv. Diagnostics (previously SVP TA Instruments Division) in SEC filings |
| Feb 9, 2026 | Claire Fraser became a director |
| Aug 14, 2024 | Heather Knight became a director |
| Jun 24, 2024 | Robert L Carpio III became SVP, Waters Division |
| Oct 18, 2023 | The company announced the departure of Jonathan M Pratt as SVP Waters Division in an SEC filing |
| Mar 27, 2023 | Richard H Fearon became a director |
| Nov 23, 2022 | Mark Vergnano became a director |
| Nov 23, 2022 | Daniel J. Brennan became a director |
| Jul 28, 2022 | The company announced the departure of Thomas P Salice from the board in an SEC filing |
| Mar 30, 2022 | The company announced the departure of John M Ballbach from the board in an SEC filing |
| Feb 22, 2022 | Amol Chaubal listed as SVP & Chief Financial Officer (previously SVP and Chief Financial Office) in SEC filings |
| Oct 5, 2021 | John M Ballbach became a director |
| Jul 14, 2021 | Wei Jiang became a director |
| May 12, 2021 | Amol Chaubal became SVP and Chief Financial Office |
| May 5, 2021 | Jonathan M Pratt listed as SVP Waters Division (previously SVP, President TA Instruments) in SEC filings |
| May 1, 2021 | Jianqing Bennett became SVP TA Instruments Division |
| Jan 11, 2021 | Belinda Hyde became SVP, Global Human Resources |
| Jan 1, 2021 | Pearl S Huang became a director |
| Sep 1, 2020 | Udit Batra became a director |
| Sep 1, 2020 | Udit Batra became President and CEO |
| Jul 9, 2020 | Daniel J. Welch became SVP Global Operations |
| Oct 1, 2019 | Keeley A Aleman became SVP General Counsel & Corp Sec |
| Sep 3, 2019 | Jonathan M Pratt became SVP, President TA Instruments |
| Sep 1, 2018 | Linda Baddour became a director |
| Sep 1, 2018 | Gary E Hendrickson became a director |
| Mar 19, 2018 | Francis Kim became SVP Global Operations |
| Feb 12, 2018 | Robert G Carson became SVP Corporate Development |
| Jan 3, 2018 | Rohit Khanna reported in an SEC filing no longer being SVP, Applied Technology |
| Dec 7, 2017 | Ian King listed as SVP, Global Products (previously SVP, Instrument Technology) in SEC filings |
| Jun 22, 2017 | Flemming Ornskov became a director |
| May 8, 2017 | Ian King listed as SVP, Instrument Technology (previously Sr VP, Instrument Technology) in SEC filings |
| May 5, 2017 | Terrence P Kelly listed as SVP, President TA Instruments (previously President, TA Instruments) in SEC filings |
| May 1, 2017 | Eugene G Cassis listed as SVP (previously Chief Financial Officer) in SEC filings |
| Feb 21, 2017 | Rohit Khanna listed as SVP, Applied Technology (previously Sr VP, Applied Technology) in SEC filings |
| Feb 10, 2017 | David Terricciano listed as SVP, Global Operations (previously Sr VP, Global Operations) in SEC filings |
| Jan 9, 2017 | Sherry Buck became SVP and CFO |
| Dec 13, 2016 | Michael C Harrington listed as SVP, Global Markets (previously Sr VP, Global Markets) in SEC filings |
| Dec 13, 2016 | Mark T Beaudouin listed as SVP and General Counsel (previously VP and General Counsel) in SEC filings |
| Dec 13, 2016 | Elizabeth B Rae listed as SVP, Global HR (previously Corporate VP of HR) in SEC filings |
- Prev
- 1
Not reported recently (24)
- Edward Conard · Last reported as a director in an SEC filing dated Apr 5, 2023
- Gary E Hendrickson · Last reported as a director in an SEC filing dated May 9, 2022
- Michael F Silveira · Last reported as VP, Corporate Controller in an SEC filing dated May 4, 2022
- Keeley A Aleman · Last reported as SVP General Counsel & Corp Sec in an SEC filing dated Mar 10, 2022
- Daniel J. Welch · Last reported as SVP Global Operations in an SEC filing dated Feb 25, 2022
- Belinda Hyde · Last reported as SVP, Global Human Resources in an SEC filing dated Feb 22, 2022
- Michael J Berendt · Last reported as a director in an SEC filing dated Aug 16, 2021
- Joann A Reed · Last reported as a director in an SEC filing dated Mar 8, 2021
- Michael C Harrington · Last reported as SVP, Global Markets in an SEC filing dated Mar 3, 2021
- Ian King · Last reported as SVP, Global Products in an SEC filing dated Mar 3, 2021
- Robert G Carson · Last reported as SVP Corporate Development in an SEC filing dated Mar 3, 2021
- Sherry Buck · Last reported as SVP and CFO in an SEC filing dated Nov 2, 2020
- Elizabeth B Rae · Last reported as SVP, Global HR in an SEC filing dated Aug 21, 2020
- Christopher J OConnell · Last reported as CEO and President in an SEC filing dated Aug 3, 2020
- Francis Kim · Last reported as SVP Global Operations in an SEC filing dated Mar 4, 2020
- Laurie H M.D. Glimcher · Last reported as a director in an SEC filing dated Jan 3, 2020
- Mark T Beaudouin · Last reported as SVP and General Counsel in an SEC filing dated Nov 18, 2019
- Terrence P Kelly · Last reported as SVP, President TA Instruments in an SEC filing dated Mar 12, 2019
- David Terricciano · Last reported as SVP, Global Operations in an SEC filing dated Mar 1, 2018
- Eugene G Cassis · Last reported as SVP in an SEC filing dated Feb 16, 2018
- William J Miller · Last reported as a director in an SEC filing dated Dec 6, 2017
- Douglas A Berthiaume · Last reported as a director in an SEC filing dated Nov 6, 2017
- Joshua Bekenstein · Last reported as a director in an SEC filing dated Jan 5, 2017
- Arthur G Caputo · Last reported as EVP and President, Waters Div in an SEC filing dated Dec 7, 2016
WAT Proposed Insider Sales (Form 144)
Latest: 2026-08-06What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | KUEBLER CHRISTOPHER A | Director | 3,626 | $1.44M | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-05-15 | KUEBLER CHRISTOPHER A | Director | 4,000 | $1.45M | 2024-05-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-03-13 | BADDOUR LINDA | Director | 500 | $177.8K | 2024-03-13 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-12-15 | Pratt Jonathan M | Former Officer | 2,116 | $678.8K | 2023-12-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-12-08 | Pratt Jonathan M | Former Officer | 2,158 | $633.0K | 2023-12-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-11-15 | Pratt Jonathan M | Former Officer | 8,758 | $2.34M | 2023-11-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-08-04 | KUEBLER CHRISTOPHER A | Director | 4,000 | $1.17M | 2023-08-04 | Fidelity Brokerage Services LLC | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-22 | 0001193125-26-236929 | EDGAR |
| 2026-05-05 | 0001193125-26-204955 | EDGAR |
| 2026-03-23 | 0001193125-26-119753 | EDGAR |
| 2026-03-16 | 0001193125-26-107339 | EDGAR |
| 2026-02-09 | 0001193125-26-041897 | EDGAR |
| 2026-02-09 | 0001193125-26-042819 | EDGAR |
| 2026-01-27 | 0001193125-26-024492 | EDGAR |
| 2026-01-16 | 0001193125-26-015384 | EDGAR |
| 2026-01-12 | 0001193125-26-010633 | EDGAR |
| 2025-11-04 | 0001193125-25-263520 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-23 | 0001193125-26-062604 | EDGAR |
| 2025-02-25 | 0001193125-25-034579 | EDGAR |
| 2024-02-27 | 0001193125-24-047491 | EDGAR |
| 2023-02-27 | 0001193125-23-050827 | EDGAR |
| 2022-02-24 | 0001193125-22-051509 | EDGAR |
| 2021-02-24 | 0001193125-21-054385 | EDGAR |
| 2020-02-25 | 0001193125-20-048303 | EDGAR |
| 2019-02-26 | 0001193125-19-051872 | EDGAR |
| 2018-02-27 | 0001193125-18-060830 | EDGAR |
| 2017-02-24 | 0001193125-17-056239 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-12 | 0001193125-26-219487 | EDGAR |
| 2025-11-04 | 0001193125-25-263533 | EDGAR |
| 2025-08-04 | 0001193125-25-172087 | EDGAR |
| 2025-05-06 | 0001193125-25-113274 | EDGAR |
| 2024-11-01 | 0001193125-24-249126 | EDGAR |
| 2024-07-31 | 0001193125-24-189466 | EDGAR |
| 2024-05-07 | 0001193125-24-132558 | EDGAR |
| 2023-11-07 | 0001193125-23-271909 | EDGAR |
| 2023-08-02 | 0001193125-23-201115 | EDGAR |
| 2023-05-09 | 0001193125-23-138998 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.06% | $1.4B | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.07% | $1.1B | — | 2026-09-30 |
| 3 | VO Vanguard Morningstar Mid-Cap ETF | Vanguard | 0.43% | $924.4M | — | 2026-09-30 |
| 4 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.07% | $596.7M | $878.4B | 2026-10-21 |
| 5 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.07% | $552.0M | $820.7B | 2026-10-21 |
| 6 | VOT Vanguard Morningstar Mid-Cap Growth ETF | Vanguard | 1.02% | $338.9M | — | 2026-09-30 |
| 7 | VUG Vanguard Morningstar Growth ETF | Vanguard | 0.08% | $331.7M | — | 2026-09-30 |
| 8 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.69% | $328.5M | $47.5B | 2026-10-21 |
| 9 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.22% | $221.8M | — | 2026-10-21 |
| 10 | VTV Vanguard Morningstar Value ETF | Vanguard | 0.08% | $205.6M | — | 2026-09-30 |
| 11 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.33% | $188.3M | $57.2B | 2026-10-21 |
| 12 | PHO Invesco Water Resources ETF | Invesco | 7.49% | $147.4M | — | 2026-10-21 |
| 13 | TCAF T. Rowe Price Capital Appreciation Equity ETF | Nport | 1.79% | $132.4M | — | 2026-06-30 |
| 14 | VHT Vanguard Health Care ETF | Vanguard | 0.60% | $131.8M | — | 2026-09-30 |
| 15 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.07% | $124.0M | $184.5B | 2026-10-21 |
| 16 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.12% | $100.5M | $84.8B | 2026-10-21 |
| 17 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.10% | $88.3M | — | 2026-10-21 |
| 18 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.13% | $80.3M | — | 2026-05-31 |
| 19 | FIW First Trust Water ETF | First Trust | 4.47% | $78.9M | $1.8B | 2026-10-21 |
| 20 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.15% | $74.7M | $50.7B | 2026-10-21 |
| 21 | QUAL iShares MSCI USA Quality Factor ETF | iShares (BlackRock) | 0.15% | $73.8M | $48.7B | 2026-10-21 |
| 22 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.44% | $68.4M | $15.7B | 2026-10-21 |
| 23 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.06% | $58.4M | $96.2B | 2026-10-21 |
| 24 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.15% | $56.9M | $38.4B | 2026-10-21 |
| 25 | EQTY KOVITZ CORE EQUITY ETF | Nport | 3.73% | $53.1M | — | 2026-07-31 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-07-04 | $1.65B | $-136.00M | $-1.39 | $201.00M |
| Q1 '26 | 2026-04-04 | $1.27B | $-72.00M | $-0.87 | $-3.00M |
| Q4 '25 | 2025-12-31 | $932.36M | $225.21M | $3.76 | $164.55M |
| Q3 '25 | 2025-09-27 | $799.89M | $148.92M | $2.50 | $187.31M |
| Q2 '25 | 2025-06-28 | $771.00M | $147.00M | $2.47 | $41.00M |
| Q1 '25 | 2025-03-29 | $662.00M | $121.00M | $2.03 | $260.00M |
| Q4 '24 | 2024-12-31 | $872.71M | $231.40M | $3.88 | $240.14M |
| Q3 '24 | 2024-09-28 | $740.30M | $161.50M | $2.71 | $204.58M |
| Q2 '24 | 2024-06-29 | $708.53M | $142.74M | $2.40 | $54.53M |
| Q1 '24 | 2024-03-30 | $636.84M | $102.20M | $1.72 | $262.87M |
| Q4 '23 | 2023-12-31 | $819.47M | $216.21M | $3.65 | $230.12M |
| Q3 '23 | 2023-09-30 | $711.69M | $134.55M | $2.27 | $157.82M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.